Product Images Levetiracetam

This text is a medication label for Levetiracetam USP 250 mg tablets by Aurobindo Pharma Limited. It includes dosage recommendations for the drug and instructions for pharmacists to dispense it in a light-resistant container. The medication should be stored between 20°C to 25°C (68°F to 77°F) or between 15°C to 30°C (59°F to 86°F). The text also includes product codes and manufacturing information.*

The figure shows the responder rate in Study 1 which resulted in a 250% reduction from baseline. The percentages range from 0% to 39.6%, with the statistically significant result indicated as compared to placebo. The text also mentions the use of Leviaseam at different concentrations.*

This is a medication bottle label for Levetiracetam Tablets USP with a strength of 1000 mg. The label provides information for the pharmacist to dispense the medication with the provided medication guide. The recommended dosage can be found in the package insert. The medication should be dispensed in a light-resistant container and stored at temperatures between 20°C to 25°C. The medication is manufactured by Aurobindo Pharma Limited in Hyderabad, India, and is distributed by BluePoint Laboratories. The label also includes a product code, batch number, and revision date.*

The image shows the responder rates of patients in Study 2 for a specific period, with a comparison between the placebo group and two groups taking different doses of the medication Levetiracetam. One of the Levetiracetam dosages resulted in a statistically significant improvement compared to the placebo group.*

The text describes a figure, which shows the responder rate of two groups in "Study 3". The figure shows a chart with percentages on the y-axis and two groups, "Placebo" and "Levetiracetam 3000 mg/day", on the x-axis. The responder rate, defined as a >50% reduction from baseline, for each group is shown as a bar in the chart. The Levetiracetam group has a higher responder rate (45%) than the Placebo group (39.4%). The figure also notes that the difference between the two groups is statistically significant.*

The text describes a figure (Figure 4), which shows the responder rate in a study (Study 4) based on a 50% reduction from baseline. The figure demonstrates that the responder rates for the placebo group and the group treated with Levetiracetam were 44.6% and 45%, respectively. The graph also indicates that the Levetiracetam group demonstrated a statistically significant difference compared to the placebo group.*

The text is describing a figure labeled "Figure 5" which shows the Responder Rate for patients between the ages of 1 month to less than 4 years. The rate is plotted as a percentage, with Lovetracatam and Placebo being the two treatments being compared. Lovetracatam had a statistically significant (>50%) reduction from baseline compared to Placebo.*

This is a medication called Levetiracetam in the form of tablets. Each film-coated tablet contains 500mg of Levetiracetam USP. It is manufactured by Aurobindo Pharma Limited in Hyderabad, India, and sold by BluePoint Laboratories in a bottle of 120 tablets. The recommended dosage is available in the package insert. Pharmacists are advised to dispense it in a tightly closed, light-resistant container with a child-resistant closure. It has to be stored at room temperature between 20°C to 25°C and excursions permitted to 15°C to 30°C. However, the text doesn't provide any information regarding the unwinding direction.*

This is a description of a medication called Levetiracetam. It is in the form of film-coated tablets with a dosage of 750 mg. The recommended dosage should be obtained from the package insert. The pharmacist should dispense it in a tightly packed light-resistant container with a child-resistant closure. The medication guide should be provided separately to the patient. It should be stored at a temperature range of 20°C to 25°C and excursions are permitted from 15°C to 30°C. The manufacturer is Aurobindo Pharma Limited located in Hyderabad, India. *